Stocks
Trump bought up to $65,000 in Moderna stock — after FDA approval and a cancer vaccine breakthrough, his total gains topped 225%
The president’s investment is now worth significantly more, raising fresh questions about his stock trades as the biotech company scores a major cancer breakthrough.
'Sometimes the opportunity is too great': Jim Cramer says you 'can't afford not to' own these soaring memory stocks
Memory chips are currently the ‘bottleneck’ for AI infrastructure. But that doesn’t ensure the stocks will continue to outperform forever.
3 Harvard dropouts, all age 24, just hit a $21B valuation with a chip they say beats Nvidia's best — should NVDA and ETF investors worry?
After securing $1 billion in sales, Etched claims its chips are the future of AI inference.
